Techniques in Coloproctology
Cure8 research brief
Why This Matters
This study identifies factors linked to permanent ileal pouch failure after surgery for ulcerative colitis and provides a nomogram to estimate individual risk — information that can affect surgical counseling and planning, especially for patients exposed to biologic therapy before surgery.
Who Should Pay Attention
Patients considering ileal pouch–anal anastomosis (post-colectomy) — especially those with preoperative biologic exposure; colorectal surgeons; IBD clinicians.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study reviewed 851 adults with ulcerative colitis who underwent restorative proctocolectomy with ileal pouch–anal anastomosis at a European tertiary center to identify factors linked to permanent pouch failure.
Over a median follow-up of 37 months, 4.7% experienced pouch failure (permanent pouch excision or indefinite fecal diversion); most failures occurred after 12 months and were commonly driven by severe fistulae and chronic leaks. Preoperative biologic therapy was reported as the only independent predictor of pouch failure in the penalized regression model.
Handsewn anastomosis and non-standard pouch configurations were also associated with higher failure risk. The authors created a five-variable nomogram to estimate individualized failure probabilities for surgical counseling. This brief summarizes the abstract provided by the journal and does not represent a full review of the complete article text.
Keep In Mind
Retrospective single-center cohort with median follow-up of 37 months; the article abstract was the source for this summary and not a full independent appraisal.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationTechniques in Coloproctology
PublisherSpringer Science and Business Media LLC
AuthorsT. Violante, G. Calini, S. Cardelli +4 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 17, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Alma Mater Studiorum - Università di Bologna
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Rectal stump management in paediatric ulcerative colitis—An international survey for the ESPGHAN PORTO IBD group study
The survey highlights wide variation in how rectal stumps are assessed and managed after colectomy in children with UC, indicating uncertainty and a gap in standardised care that could affect outcomes and follow-up...
Sequential Biologic, Small-Molecule, and GLP-1 Analogue Therapy in Postcolectomy Enteritis With High Output Stoma.
People with ulcerative colitis who have had colectomy can rarely develop inflammation of the small intestine and high-output stomas that are hard to control.
Human factors validation study of a disposable autoinjector (Bmab 1200 autoinjector) for subcutaneous delivery of Ustekinumab.
Autoinjectors can make long-term biologic treatment easier, more convenient, and potentially improve adherence for people with Crohn’s disease or ulcerative colitis who use ustekinumab.